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ABSTRACT
The Cockayne syndrome B (CSB) protein—defective
in a majority of patients suffering from the
rare autosomal disorder CS—is a member of the
SWI2/SNF2 family with roles in DNA repair and
transcription. We demonstrate herein that purified
recombinant CSB and the major human apurinic/
apyrimidinic (AP) endonuclease, APE1, physically
and functionally interact. CSB stimulates the AP
site incision activity of APE1 on normal (i.e. fully
paired) and bubble AP–DNA substrates, with the
latter being more pronounced (up to 6-fold). This
activation is ATP-independent, and specific for
the human CSB and full-length APE1 protein, as no
CSB-dependent stimulation was observed with
Escherichia coli endonuclease IV or an N-terminal
truncated APE1 fragment. CSB and APE1 were
also found in a common protein complex in
human cell extracts, and recombinant CSB, when
added back to CSB-deficient whole cell extracts,
resulted in increased total AP site incision capacity.
Moreover, human fibroblasts defective in CSB were
found to be hypersensitive to both methyl meth-
anesulfonate (MMS) and 5-hydroxymethyl-
20-deoxyuridine, agents that introduce base excision
repair (BER) DNA substrates/intermediates.
INTRODUCTION
Cockayne syndrome (CS) is a rare autosomal recessive
genetic disorder, classiﬁed as a segmental premature-aging
syndrome (1–3). The clinical features of this disease
include poor growth (‘cachectic dwarﬁsm’), neurological
abnormalities and cutaneous photosensitivity. However,
in contrast to xeroderma pigmentosum (XP) patients—
who also exhibit increased sensitivity to ultraviolet (UV)
irradiation—individuals with CS do not display elevated
cancer risk. CS is divided into two complementation
groups: CSA (mutation in CKN1) and CSB (mutation in
ERCC6). Of the patients suﬀering from CS,  80% have
mutations in the CSB gene (1).
The CSB protein is composed of 1493 amino acids, and
based on sequence homology, has been placed into the
SWI2/SNF2 family of proteins that harbor seven helicase-
like ATPase motifs (4,5). Although no helicase activity
has been ascribed to CSB (6,7), the protein possesses a
DNA-dependent ATPase activity (6–8). Moreover, since
puriﬁed CSB (i) promotes alterations in the DNA
conformation upon binding to the double-helix and
(ii) alters the arrangement of nucleosome complexes
(at the expense of ATP hydrolysis), the protein has been
suggested to function as a chromatin remodeling factor
(9). This function appears dependent on the ability of
the protein to wrap and unwrap DNA molecules (10).
More recently, CSB was found to possess homologous
DNA strand pairing activity (11).
Numerous studies indicate that CSB participates
in transcription-coupled nucleotide excision repair
(TC-NER), as well as in global genome DNA repair
and general transcription (1,12). In particular, CSB
mutant cells exhibit hypersensitivity to a number
of DNA-damaging agents, including UV light (4),
4-nitroquinoline-1-oxide (4-NQO) (13), and N-acetoxy-
2-acetylaminoﬂuorene (NA-AAF) (14,15). In the case of
UV, the hypersensitivity has been attributed to a speciﬁc
defect in the ability of CSB mutant cells to repair
DNA damage within actively transcribed genes (16,17).
A link of CSB to TC-NER is supported by the
observations that (i) CSB-defective cells are unable to
*To whom correspondence should be addressed. Tel: 410 558 8153; Fax: 410 558 8157; Email: wilsonda@grc.nia.nih.gov
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.recover RNA synthesis following DNA-damaging agent
treatment (4) and (ii) CSB binds RNA polymerase II when
arrested at a template lesion in vitro and promotes
recruitment of TFIIH, a factor involved in transcription
and NER (18–20). Results also indicate that CSB plays
a more general role in DNA repair, promoting
changes in the chromatin structure to facilitate damage
processing, particularly within active genes (21), and
assists RNA polymerase I- or II-directed transcription
(18,22–25).
Accumulating evidence suggests a role for CSB in base
excision repair (BER) (1). BER is responsible for
correcting most spontaneous, oxidative, or alkylation
forms of DNA base or sugar damage. The observation
that CSB
 /  cells, at least certain cell types, display
hypersensitivity to agents that generate reactive oxygen
species (ROS), such as IR, paraquat and hydrogen
peroxide, supports a role for the encoded protein in the
repair of oxidative lesions (26–28). Moreover, biochemical
assays using extracts from mutant cells indicate that CSB
is responsible for promoting incision at 8-oxo-dG, a
frequent oxidative base lesion and a marker of oxidative
damage (26,29). In fact, global genome as well as
mitochondrial DNA repair of 8-oxo-dG requires a
functional CSB gene product in vivo (30–32). CSB
mutant cells also exhibit a defect in the global repair of
8-hydroxyadenine, another oxidative base modiﬁcation
(33). Work from Flohr et al. (34) suggests that the eﬃcient
repair of oxidative base lesions through poly(ADP-ribose)
polymerase 1 (PARP-1), a key DNA damage response
protein, is likewise dependent on CSB. In addition,
Thorslund et al. (35) identiﬁed a physical and functional
interaction between CSB and PARP-1, and reported
that poly(ADP)-ribosylation of CSB inhibits its DNA-
dependent ATPase activity. Spivak et al. (36) have shown
that reactivation of a plasmid containing a thymine
glycol is defective in CSB mutant cells, further support-
ing a role for this protein in oxidative DNA damage
repair. Although evidence exists for a function of CSB
speciﬁcally in TC-BER, such a role has recently become
unclear (37). It has been postulated that a defect in gene-
speciﬁc and/or global genome repair of endogenous DNA
damage gives rise to the premature-aging symptoms and
increased neurological deﬁciencies associated with CS
patients (38).
In mammalian cells, APE1 is the major apurinic/
apyrimidinic (AP) endonuclease, operating to initiate
repair of mutagenic and cytotoxic AP sites by incising
the DNA backbone immediately adjacent to the lesion
(39). AP sites are formed by spontaneous base loss
(at a frequency of  10000 events per mammalian
genome per day), as well as by increased base release
due to chemical modiﬁcation (e.g. alkylation or oxidation)
or through the action of DNA repair glycosylases that
excise speciﬁc base damages. Following APE1 incision,
subsequent participants of the BER pathway remove the
50-terminal abasic fragment, replace the damaged nucleo-
tide and seal the ﬁnal nick to restore genome integrity. We
describe herein data indicating a role for CSB in the repair
of BER substrates/intermediates, and a speciﬁc functional
interaction of CSB with the predominant AP site repair
enzyme, APE1.
MATERIALS AND METHODS
Dot-blot interaction screen
The DiscoverLight Protein Array Kit (Pierce, Rockford,
IL, USA) was used to screen for interactions between
puriﬁed CSB and select proteins. As described elsewhere
(40,41), various protein amounts were spotted on the
membranes, which were then dried and blocked in PBS-T
(1 PBS, 0.1% Tween 20) containing 5% bovine serum
albumin (BSA) for 1h at room temperature. The
membranes were then incubated with CSB (10ng/ml) for
1h at room temperature. A duplicate membrane was
incubated with blocking buﬀer alone as a control for
possible cross-reactivity with the CSB antibody. After
washing with PBS-T, the membranes were probed with
monoclonal mouse anti-CSB antibody (1 : 2000, kindly
provided by Dr Jean Marc-Egly, Institut de Ge ´ ne ´ tique
et de Biologie Mole ´ culaire et Cellulaire) overnight.
After washing, the membranes were incubated with
secondary antibody (1 : 10000, anti-mouse IgG-horse-
radish peroxidase (HRP); Vector, Burlingame, CA, USA)
for 1h at room temperature, washed again and then
developed with the SuperSignal West Pico chemilumines-
cent kit (Pierce).
Direct and indirect ELISA
Full-length, recombinant CSB and APE1 proteins were
expressed and puriﬁed as previously detailed (8,42).
Enzyme-linked immunosorbent assays (ELISAs) were
performed essentially as described (43). Brieﬂy, in the
direct ELISAs, either BSA or APE1 (30fmol) was coated
onto a 96-well plate and then incubated with increasing
amounts of CSB for 2h at 378C. After several washes,
bound CSB was detected with anti-CSB antibody,
followed by HRP-conjugated secondary antibody. For
the indirect ELISA, either CSB (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) or APE1
(Trevigen, Gaithersburg, MD, USA) polyclonal antibody
was coated overnight at 48C on a 96-well plate, and then
incubated with either CSB (6fmol=1ng) or APE1
(30fmol=1ng) protein, respectively. After incubation
with increasing amounts of the partner protein
(i.e. APE1 or CSB) for 2h at 378C, bound protein was
detected with either CSB or APE1 (Trevigen) mono-
clonal antibodies, followed by the secondary antibody
steps described above. Where indicated, ethidium bro-
mide (Invitrogen, Carlsbad, CA, USA) or DNase I
(Sigma–Aldrich, St Louis, MO, USA) was added at
10mg/ml or 5mg/ml, respectively. The protein interaction
was detected using OPD substrate (Sigma–Aldrich).
Reactions were terminated after 3min incubation with
3N H 2SO4 and plates were read at 490nm using a
Bio-Rad Benchmark Plus microplate spectrophotometer
and Microplate Manager 5.2 software (Bio-Rad
Laboratories, Hercules, CA, USA).
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ECFP-CSB-CS1AN cells, which were created as described
(8), were lysed in radioimmunoprecipitation assay (RIPA)
buﬀer [50mM Tris–HCl (pH 7.4), 1% NP-40, 0.25%
Na-deoxycholate, 150mM NaCl, 1mM EDTA, 1mM
phenylmethylsulfonyl ﬂuoride, 1mM Na3VO4,1 m M
NaF, 10U/ml DNase I and 1 tablet Complete protease
inhibitor cocktail (Roche, Basel, Switzerland) per 50ml]
by sonication. After cell disruption, the suspension was
centrifuged at 14000g for 15min. The supernatant
represented the whole cell extract, and the protein
concentration was determined using the Bio-Rad Protein
Assay (Bio-Rad Laboratories). For immunoprecipitation,
ECFP–CSB whole cell extracts were pre-cleared with
Protein G-Agarose beads (Invitrogen). The pre-cleared
extracts (4mg each) were then immunoprecipitated with
either negative control rabbit IgG antibody (Santa Cruz
Biotechnology), living colors full-length A.v. (i.e. anti-
ECFP; 1:100) polyclonal rabbit antibody (BD bio-
sciences, San Jose, CA, USA), or mouse monoclonal
APE1 antibody (Novus, Littleton, CO; 1:50) for over-
night at 48C. Samples were next incubated with Protein G-
Agarose beads (30ml) at 48C for 1h, followed by multiple
washes. Bound proteins were eluted by boiling in SDS
sample buﬀer and were analyzed by SDS-PAGE and
western blotting using mouse anti-CSB (1:1000; Dr Egly),
or mouse anti-APE1 (1:1000; Novus) antibodies, fol-
lowed by chemiluminescent analysis (Pierce).
AP endonuclease assay
The AP site-containing (i.e. the tetrahydrofuran, F,
analog) 42-mer oligonucleotides used were: CCGCT
GAATTGCACCCTCGAFCTAGGTCGATGATCCTA
AGCA (42F-11), TGCTTAGGATCATCGACCTAGG
TCGAGGGTGCAATTCAGCGG (42F comp) and TG
CTTAGGATCATCGAGGATCGAGCTCGGTGCAAT
TCAGCGG (42F bubble comp). Following the genera-
tion of normal (42F-11:42 comp) or bubble (42F-11:42F
bubble comp)
32P-end labeled duplex substrates, incision
assays were performed at 378C for 10min with APE1
(10 or 30fmol) and analyzed on denaturing polyacryla-
mide gels as previously described (44). Reactions consisted
of 50mM HEPES-KOH, pH 7.4, 50mM KCl, 5%
glycerol, 10mM MgCl2, 100mg/ml BSA, 0.05% Triton
X-100 and 200fmol of DNA. Where indicated, increasing
amounts of CSB were added. Escherichia coli endonu-
clease IV and truncated 29APE1 were puriﬁed as
described (42). Whole cell extract total AP endonuclease
activity was determined for CSB-V and CSB-WT cells
according to previously published methods (45).
Immunodepleted CSB supernatant fractions were
obtained according to the procedure of (8). In brief,
15mg of recombinant HA/His-tagged CSB was mixed with
protein A magnetic beads (New England Biolabs, Ipswich,
MA, USA) that had been pre-incubated with rabbit
polyclonal anti-HA antibody (Santa Cruz Biotechnology).
After an overnight incubation, the supernatant was
separated from the beads by centrifugation, and kept as
the immunodepleted fraction (ID CSB). Beads were
washed and CSB was eluted with 0.5mg/ml of HA
peptide in buﬀer A (8) containing 0.5M KCl to generate
the immunoprecipitated (or immunopuriﬁed) CSB protein
(IP CSB).
APsite measurements
The number of AP sites in isolated chromosomal
DNA was determined using an aldehyde reactive
probe reagent (N0-aminooxymethyl-carbonyl-hydrazino-
D-biotin) and the DNA damage quantiﬁcation kit of
Dojindo Molecular Technology (Gaithersburg, MD,
USA) as described (46).
Cellular sensitivity assays
CS1AN.S3.G2 SV40-transformed human skin ﬁbroblast
cell lines (4,47)—stably transfected with either the
mammalian expression vector pcDNA3.1 (CSB-V),
pcDNA3.1 containing the wild-type human CSB gene
(CSB-WT), or pcDNA3.1 containing the E646Q ATPase
domain II mutant CSB (CSB-E646Q) (48)—were cultured
in Minimal Essential Medium plus 15% fetal bovine
serum, antibiotics and 400mg/ml of geneticin (Invitrogen).
To investigate methyl methanesulfonate (MMS) and
5-hydroxymethyl-20-deoxyuridine (HmdU) sensitivity,
colony forming assays were performed essentially as
described (49). Brieﬂy, 5 10
2 cells were plated onto a
60-mm dish, incubated for 16h, and then treated with
diﬀerent concentrations of MMS for 1h. For HmdU
treatment, cells were plated in complete medium at a
density of 5 10
4 cells per 35-mm dish. After overnight
incubation, HmdU was added, and the cells were
incubated for an additional 24h to permit incorporation.
After agent treatment, cells were re-plated in complete
media at a density of 1 10
2 per 60-mm dish. Colonies
were stained and counted after 10 days of growth.
RNA synthesis recovery
CSB-V and CSB-WT cells were grown in the presence of
[
14C]thymidine (0.02mCi/ml, Amersham or GE health-
care) for 3 days to label chromosomal DNA. Cells were
then washed with PBS prior to a 1h treatment with 1mM
MMS. Fresh media was subsequently added to allow cells
to recover prior to measuring RNA synthesis at the
indicated times. To measure transcription, cells were
pulse-labeled with 5mCi/ml [
3H]uridine for 1h at 378C,
washed twice with PBS, and lysed in 10mM Tris (pH 8.0),
150mM NaCl, 1mM EDTA buﬀer containing 0.5%
SDS and 100mg/ml proteinase K for 1h at 378C.
Trichloroacetic acid (TCA) (20%) was added to the cell
lysate and the samples were spotted onto glass ﬁber discs
(Whatman, Maidstone, UK). The ﬁlters were sequentially
washed in 5% TCA, 70% ethanol and acetone. The
TCA-precipitable radioactivity was scintillation-counted.
RESULTS
APE1and CSB physically interact
Evidence suggests a role for CSB in facilitating global
genome, and possibly transcription-coupled BER (1). As a
means of elucidating the molecular involvement of CSB in
Nucleic Acids Research, 2007, Vol. 35, No. 12 4105BER, we examined for physical interactions of CSB with
proteins operating in this and related DNA repair
pathways. Speciﬁcally, initial studies employed a dot
blot technique, where select proteins were (i) spotted and
ﬁxed to a capture membrane, (ii) incubated with puriﬁed
CSB in solution and (iii) probed for binding of CSB using
CSB-speciﬁc antibodies. Potential interactors identiﬁed
using this technique were the strand break sensor protein
PARP-1 (data not shown), the structure-speciﬁc endonu-
clease FEN1, the tyrosine kinase c-Abl and the major
human abasic endonuclease APE1 (Supplementary
Figure 1A: See online supplementary material for a
color version of this ﬁgure). No signiﬁcant interaction
was seen with the tumor suppressor p53, the replication
processivity factor PCNA, the end-joining binding com-
plex Ku70/80, the Werner helicase, the protein defective in
Nijmegen Breakage Syndrome NBS1, the telomere repeat
binding protein TRF1, the recombination protein Rad51
and the single-stranded DNA binding protein RPA
(Supplemental Figure 1A and data not shown). Detailed
studies describing the interaction of CSB with PARP-1
have been reported elsewhere (35), and experiments with
other putative binding partners (e.g. c-Abl and FEN1) are
ongoing.
To interrogate the CSB–APE1 interaction further, we
performed both direct and indirect ELISAs. Direct
ELISAs, where APE1 was bound to the microtiter dish
surface, supported that CSB physically interacts with
APE1, as revealed by a concentration-dependent increase
in the CSB protein signal that is not observed with the
negative control protein BSA (Supplementary Figure 1B:
See online Supplementary Data for a color version of this
ﬁgure).Reciprocal experiments, however, where CSB was
ﬁxed to the surface, did not reveal an interaction (data not
shown).
Thus, as an alternative method, an indirect ELISA
approach, where either an APE1- (Figure 1A) or CSB-
speciﬁc (Figure 1B) antibody was bound to the dish ﬁrst
and then incubated with the appropriate puriﬁed protein,
was employed. In these studies, a reciprocal interaction
was observed (albeit weaker when using APE1 as the
binding probe; Figure 1B), and the increased signal in
both cases was generally unaﬀected by the presence of
ethidium bromide (EtBr) or DNase I (Figure 1A and B).
The APE1 and CSB antibodies also did not cross-react
non-speciﬁcally in the indirect ELISA experiments. These
ﬁndings indicate that the APE1–CSB binding is the
product of a direct, physical association and is indepen-
dent of DNA. Analysis of the indirect ELISA experiments
revealed an apparent binding aﬃnity (i.e. the concentra-
tion at which approximately half maximal binding was
observed) for CSB and APE1 of  4.5 (when APE1 was
coated) to  20 nM (when CSB was coated).
APE1and CSB arein acommon complexwithin
human cell extracts
We next examined whether APE1 and CSB existed in a
common protein complex in human cell extracts using
immunoprecipitation techniques. CSB mutant human cells
(i.e. CS1AN.S3.G2) transfected with the pECFP–CSB
expression vector were employed [ECFP-CSB-CS1AN;
(8)], largely because antibodies directed against human
CSB worked inconsistently in our hands in immuno-
precipitation experiments. As shown in Figure 1C,
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Figure 1. CSB associates with APE1. Interaction between CSB and
APE1 in indirect ELISA. Mouse anti-APE1 (panel A) or anti-CSB
(panel B) was coated to the well. Puriﬁed APE1 (30fmol, 1ng) or CSB
(6fmol, 1ng) was then bound to the appropriate antibody. These
complexes were next incubated with diﬀerent concentrations of CSB
(panel A) or APE1 (panel B) as indicated. Ethidium bromide (EtBr) or
DNase I was added where indicated. Values are means standard
errors (n=3). (C) CSB and Ape1 are in a common complex in human
cell extracts. Lysates from CS1AN cells transfected with the ECFP-CSB
plasmid were immunoprecipitated (IP) with either ECFP (left) or APE1
(right) antibodies. The IPs were then analyzed by immunoblotting (IB)
with either anti-CSB or anti-APE1 antibodies. Lysates of 10% of the
amount used for IP were loaded as input comparisons. As controls,
lysates IPed with rabbit IgG only were loaded (IgG Control), and IPs
with anti-ECFP were performed on extracts from ECFP-only expres-
sing cells (Vector Control).
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ECFP or APE1 pulled down both CSB and APE1
simultaneously from the ECFP-CSB-complemented
CS1AN extracts. In contrast, neither the IgG antibody
alone (negative control) nor the anti-ECFP antibody
used against extracts containing only the ECFP
fusion portion (vector control) precipitated either repair
protein (Figure 1C). Semi-quantitative densitometry
analysis of the western blot signals indicated that,
depending on the experiment, between roughly 5% and
50% of either APE1 or CSB was co-immunoprecipitated
with the other protein. The reason for the variability is
presently unknown, but may reﬂect diﬀerences in cell
culture conditions, cell cycle status or experimental
handling.
CSB stimulates APE1 endonuclease activity
As APE1 and CSB were found to physically interact and
co-immunoprecipitate from human cell extracts
(Supplementary Figure 1 and Figure 1), we next explored
whether this association had a functional eﬀect on either
APE1 or CSB enzymatic activities. Using a 42F normal
(i.e. fully base-paired) duplex or a 42F 11-nt bubble
substrate [where F is an abasic site analog (50)], we
measured the eﬀect of CSB on APE1 AP site incision
activity. As shown in Figure 2A, APE1 cleavage of normal
double-stranded AP–DNA was stimulated signiﬁcantly in
a CSB concentration-dependent manner, with roughly
a 2-fold activation being observed at a molar ratio of
APE1 to CSB of 1 : 3, and a 4-fold activation being
detected at a 1 : 10 APE1 to CSB ratio. As expected,
CSB itself exhibited no AP endonuclease activity.
Moreover, no activation was observed with the CSB
storage buﬀer (Figure 2A), suggesting that the stimulation
was dependent on the CSB protein itself.
With the 11-nt AP site-containing bubble substrate,
which mimics a DNA transcription intermediate (44),
CSB protein was again found to stimulate APE1
endonuclease activity in a concentration-dependent
manner (Figure 2B). Signiﬁcantly, CSB activation at
either an equal molar ratio (2-fold) or at a higher ratio
(up to 6-fold) was more profound with the bubble
substrate than with the fully paired AP duplex (up to
4-fold). This observation suggests some DNA speciﬁcity in
the activation, and is consistent with the higher aﬃnity of
CSB for transcription bubble structures than for normal
double-stranded DNA (8)—an observation that supports
that the stimulatory eﬀect on APE1 is CSB-dependent. As
above, CSB did not itself display AP endonuclease activity
on the bubble substrate. Notably, addition of ATP did not
aﬀect the CSB stimulation of APE1 (Figure 2C). Last,
APE1 had no eﬀect on CSB ATPase activity in the
presence of a 90-mer (35nt)-bubble substrate (data not
shown) or the 42F(11)-bubble substrate (Supplementary
Figure 2: See online Supplementary Data for a color
version of this ﬁgure).
To determine whether the activation of APE1 was
indeed dependent on the CSB protein, we performed
incision assays using immunodepleted and immunopreci-
pitated CSB protein fractions (see Materials and Methods
section). As revealed by silver staining, immunodepletion
of CSB with anti-HA antibodies reduced CSB protein
levels in the recovered supernatant by  90% (data not
shown). Thus, as expected, and supportive of the
stimulation being CSB-dependent, the immunodepleted
supernatant (ID CSB) had a  10-fold reduced ability to
stimulate APE1 activity; that is, roughly equal stimulation
was observed at a 10-fold higher amount of the
immunodepleted CSB extract, relative to the puriﬁed
CSB protein or the immunoprecipitated (i.e. immunopuri-
ﬁed, IP CSB) CSB protein (Figure 3A).
As another means of evaluating the speciﬁcity of the
CSB stimulation, we performed abasic site incision assays
with puriﬁed bacterial AP endonuclease IV. Endonuclease
IV is an E. coli protein with no sequence or structural
homology to the human APE1 protein, although both
enzymes exhibit many of the same biochemical repair
functions (51). As shown in Figure 3B, CSB had no eﬀect
on endonuclease IV incision activity of the 11-nt bubble
substrate, even when present at a molar ratio of 100:1 (i.e.
at 10fmol CSB); some inhibition was observed at the
higher molar ratios. This result indicates that the AP
endonuclease activation is speciﬁc to the human protein
combination (i.e. CSB and APE1). As an aside, the
ﬁndings here indicate that the ability to incise at AP sites
in transcription bubble conﬁgurations is a general
property of abasic endonucleases, both (unrelated) pro-
karyotic and eukaryotic.
We next examined whether CSB could stimulate the
endonuclease activity of a truncated APE1 protein lacking
the ﬁrst 29 amino acid residues (i.e. 29APE1). As shown
in Figure 3C, puriﬁed CSB did not activate 29APE1
incision activity of the 11nt AP site-containing 42-mer
bubble substrate, even at a molar ratio of 20:1. This result
indicates that CSB physically interacts with the unique,
unstructured N-terminal (REF-1) domain of APE1 (52)
and that the protein contact is critical for the observed
activation.
Employing a previously established electrophoretic
mobility shift assay, which omits the divalent cation
Mg
2+ essential for APE1 catalysis (53), CSB was found
not to obviously promote APE1 binding to fully paired or
bubble-containing 42-mer AP–DNAs (Supplementary
Figure 3: See online Supplementary Data for a color
version of this ﬁgure). This ﬁnding argues that the
endonuclease stimulation is mediated through a direct
physical association with the APE1 protein (perhaps by
promoting a favorable conformational change in APE1
through the N-terminal interaction) and/or the introduc-
tion of a topological alteration in the DNA substrate that
permits a more eﬃcient incision reaction. Interestingly,
APE1 induces a kink in DNA to facilitate both recogni-
tion and strand cleavage of AP sites (52). Finally, some
apparent binding of DNA was observed by CSB,
particularly at the higher protein concentrations
(Supplementary Figure 3).
The role ofCSB in global genome APsite repair
As a means of evaluating the function of CSB in in vivo AP
site repair, we measured the steady-state level of abasic
Nucleic Acids Research, 2007, Vol. 35, No. 12 4107lesions in total chromosomal DNA isolated from both
CSB-V and CSB-WT ﬁbroblasts using an established
aldehyde reactive probe method (54). These studies found
that both human cell lines maintain similar AP site levels
(Figure 4A). Consistent with this, both CSB-WT and
CSB-V whole cell extracts exhibited comparable total AP
site incision capacities on fully paired 34-mer duplex
substrates (Figure 4B and C). In addition, as with the
whole cell extracts, we did not detect any diﬀerence in
incision eﬃciency of normal duplex or bubble substrate
AP site-containing DNAs using nuclear extracts prepared
from CSB-WT or CSB-V cells (data not shown). These
results suggest that CSB does not obviously modulate
global genome repair of abasic lesions. However, the data
does not exclude a more specialized role for the CSB–
APE1 interaction in the repair of a subset of APE1
substrates, perhaps in regions of complex DNA structure.
Signiﬁcantly, addition of recombinant CSB protein to
whole cell extracts prepared from CSB-V cells resulted in a
concentration-dependent stimulation of AP site incision
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4108 Nucleic Acids Research, 2007, Vol. 35, No. 12eﬃciency (Figure 4D), supportive of the idea that
situations of high-localized concentrations of APE1 and
CSB may indeed foster AP site repair. We note that semi-
quantitative western blot analysis using CSB-WT whole
cell extracts indicated an overall ratio of APE1:CSB of
 100:1 (data not shown).
CSB contributes to MMS and HmdUresistance
As an additional means of evaluating the cellular
contribution of CSB to the repair of BER substrates/
intermediates, we determined the sensitivity of the
SV40-transformed CSB mutant ﬁbroblast cell line
CS1AN.S3.G2 complemented with either a control
vector (CSB-V) or a recombinant plasmid express-
ing wild-type human CSB (CSB-WT) (48) to the mono-
functional alkylating agent MMS and the thymidine
analog HmdU. For MMS, the most critical biological
lesion is presumed to be the N-methylation base products,
which frequently give rise to AP sites via enhanced
hydrolysis of the N-glycosylic bond or DNA glycosylase-
mediated base release (55). HmdU is an oxidative base
product formed by attack of intracellular ROS as well as
by way of deamination of HmdC, another oxidative base
lesion. Repair of HmdU in chromosomal DNA proceeds
through a SMUG1-initiated BER response (56). Prior
studies have established that exposure to exogenous
HmdU in the culture medium induces cell killing in a
manner that is dependent on the formation of BER
intermediates in DNA, and not the base itself (57). As
shown in Figure 5, CSB-V cells exhibit an  3-fold increase
in sensitivity to both MMS (panel A, 0.48mM) and
HmdU (panel B, 5.4mM), as determined by the LD37
doses relative to the CSB-WT control (MMS, 1.3mM;
HmdU, 17.1mM). These ﬁndings provide novel evidence
for a direct role of CSB in the repair of BER substrates/
intermediates, possibly AP sites or single-strand breaks
(SSBs), which are common to the two agents. As seen
previously (48), we did not detect an increased sensitivity
of the CSB-V cells (studied here) to hydrogen peroxide
(data not shown).
As ATP was not critical to the APE1 activation
(Figure 2C), we determined the contribution of the
ATPase function of CSB to MMS resistance. Our studies
reveal that CSB-deﬁcient CS1AN cells expressing an
ATPase domain II mutant CSB protein (i.e. CSB-
E646Q) display intermediate sensitivity to MMS chal-
lenges (Figure 5A). This ﬁnding indicates both a structural
and an enzymatic role for CSB in the MMS response.
DISCUSSION
We report herein that CSB and the major human AP
endonuclease, APE1, directly interact, as well as exist in a
common protein complex in human cells (Supplementary
Figure 1 and Figure 1). As seen upon UV exposure (58),
the composition of the CSB protein complex likely
changes depending on the cellular environment, perhaps
explaining the variability seen in the co-IP studies reported
within (see Results section). Investigations to further
analyze the nature of the CSB complex during diﬀerent
cell cycle stages or upon challenges with disparate DNA-
damaging agents (e.g. oxidizing or alkylating compounds)
are warranted. We also found that CSB stimulates APE1
AP site incision activity on abasic site-containing DNA
substrates—in an ATP-independent, species-speciﬁc
manner (no activation of E. coli endonuclease IV was
observed by CSB)—likely via a direct interaction with the
N-terminal ‘REF-1 region’ of APE1. This stimulation was
more pronounced on a transcription-mimic bubble
structure in comparison with a fully base-paired, ‘classical’
abasic site BER substrate (Figure 2). For instance, we
detected a 2-fold enhanced incision activity of APE1 on
the bubble duplex at a 1 : 1 CSB:APE1 molar ratio [keep
in mind that CSB likely operates as a functional dimer
(59)], whereas no stimulation was observed at this ratio on
the fully paired double-stranded AP-DNA. Thus, in
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is denoted.
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endogenous base damage repair and PARP-1 in DNA
damage responses (see Introduction section), the interac-
tion with APE1 suggests a more general function of CSB
in modulating BER processes.
Despite the strong biochemical stimulation noted
above, we found no clear evidence for a role of CSB in
the global genome repair of endogenous, natural (hydro-
lytic) abasic sites (Figure 4). However, in light of the more
pronounced activation seen with the bubble substrate,
we favor a model whereby the CSB–APE1 interaction is
most critical to regions of the genome where complex
DNA structures are formed, such as during transcription
or replication, or at sites of recombination (R-DNA or
telomeres), where the local, relative concentrations of
these proteins may also be higher. Moreover, a more
specialized role for this interaction in the repair of a
speciﬁc subset of APE1-targeted damages could exist.
For instance, CSB may promote excision of oxidized
AP sites or certain base modiﬁcations (e.g. 5,6-dihydro-
20-deoxyuridine, 5,6-dihydrothymidine, 5-hydroxy-20-
deoxyuridine, a-20-deoxyadenosine and a-thymidine
adducts), which have all been shown to be substrates for
APE1 repair activity (60,61). We note that we did not see
any obvious activation of the APE1 30 to 50 exonuclease
activity on a 30-recessed primer-template DNA duplex
(unpublished data), supporting a speciﬁcity to the
CSB–APE1 interaction.
While the idea of TCR of BER substrates is
controversial, it is possible that CSB facilitates APE1
repair within actively transcribed genes. Interestingly,
our preliminary data indicate a delayed RNA synthesis
recovery in CSB mutant cells following MMS exposure
(Supplementary Figure 4: See online Supplementary Data
for a color version of this ﬁgure), suggesting that certain
BER substrates/intermediates may indeed be handled in a
gene-speciﬁc or potentially TCR-speciﬁc manner. Prior
reports in fact indicate that hydrolytic or oxidized abasic
lesions create a pause or arrest site for elongating RNA
polymerases (62–68), and a stalled RNA polymerase is
critical for the initiation of TCR and the recruitment of
CSB (20,69). SSBs are also blocks to RNA polymerase
progression (70), whereas alkylation base damage does
not appear to be corrected in a TCR mechanism (71).
Innovative methodologies to accurately and speciﬁcally
evaluate genome (region)-speciﬁc repair and TCR of BER
lesions are needed.
To our knowledge, we provide the ﬁrst evidence
that CSB mutant cells are defective in the repair of
MMS-induced DNA damage, as well as DNA products
generated after HmdU incorporation. Since both of these
agents induce cell killing through the production of BER
substrates/intermediates, the colony survival assays herein
(Figure 5) provide compelling evidence that CSB mutant
cells are defective in the eﬃcient or productive removal of
cytotoxic BER products, likely AP sites and/or DNA
SSBs, which are common to these two agents. Consistent
with this interpretation, prior studies have documented a
clear and reproducible hypersensitivity of cells defective in
a central BER participant to MMS and HmdU challenges.
In particular, APE1, POLb, XRCC1 and PARP1 mutant
cells exhibit extreme sensitivity to both MMS (72–76) and
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4110 Nucleic Acids Research, 2007, Vol. 35, No. 12HmdU [(77–79) and unpublished data]. Thus, combined
with the reduced base damage removal and the increased
sensitivity to oxidizing agents displayed by CSB mutant
cells (see Introduction section), evidence is mounting that
supports a role for CSB in facilitating a BER-related
response.
The lack of an eﬀect of ATP on the CSB-dependent
activation of APE1, and the observation that the ATPase
mutant protein (E646Q) only partially corrects the MMS
sensitivity of CSB mutant cells (Figure 5A), suggests that
this SNF2/SWI2 family member can function in BER in a
chromatin remodeling-independent manner. This conclu-
sion is in line with previous ﬁndings that uncovered
normal hydrogen peroxide and g irradiation sensitivity, as
well as 8-oxo-dG incision activity, for CS1AN.S3.G2 cells
transfected with the E646Q mutant (26,48). These results
imply that CSB modulates BER primarily through protein
complex associations (direct or indirect), or via a more
subtle (ATP-independent) modiﬁcation of the DNA
structure. Notably, a functional ATPase activity, while
necessary for chromatin remodeling, is not required for
the induction of topological change in naked DNA (6).
Thus, a story is emerging that suggests a distinct role for
CSB in facilitating BER in comparison with NER, where
the ATPase function of the protein (and energy) is more
critical to the repair of UV-induced DNA damage (13,48).
With that said, the partial complementation of E646Q
(Figure 5A) does indicate a role for the ATPase function
(and presumably the remodeling activity) of CSB in the
MMS response as well. Further studies to more thor-
oughly deﬁne the precise biochemical contributions of
CSB to the diﬀerent DNA damage-response pathways (i.e.
the contribution of protein–protein interactions, the ATP-
dependent remodeling activity, or the ability to manip-
ulate naked DNA) are a priority.
In summary, we report a physical and functional
interaction between CSB and APE1, where the CSB-
dependent stimulatory eﬀect on APE1 incision activity,
particularly on a bubble structure, is quite pronounced
relative to other APE1 interactions (80). Moreover, we
demonstrate that CSB mutant cells exhibit a profound
hypersensitivity to DNA-damaging agents that create
BER-type substrates/intermediates, namely MMS and
HmdU, and display an impaired RNA synthesis recovery
following MMS exposure. These ﬁndings provide further
evidence for a role of CSB in the processing of BER-
speciﬁc DNA substrates, potentially in regions of the
genome that take on complex structures.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank Mr Daniel R. McNeill (NIA) for assistance with
a number of the experiments within and Mr Alfred May
(NIA) for technical advice on this project. We thank Dr
Robert Brosh and Dr. Mohammad Hedayati (NIA) for
critical reading of this manuscript. This research and
funding to pay the Open Access publication charges for
this article were supported by the Intramural Research
Program of the National Institute on Aging, NIH.
Conﬂict of interest statement. None declared.
REFERENCES
1. Licht,C.L., Stevnsner,T. and Bohr,V.A. (2003) Cockayne syndrome
group B cellular and biochemical functions. Am. J. Hum. Genet., 73,
1217–1239.
2. Lehmann,A.R. (2003) DNA repair-deﬁcient diseases, xeroderma
pigmentosum, Cockayne syndrome and trichothiodystrophy.
Biochimie, 85, 1101–1111.
3. Cleaver,J.E. (2005) Cancer in xeroderma pigmentosum and related
disorders of DNA repair. Nat. Rev. Cancer, 5, 564–573.
4. Troelstra,C., van Gool,A., de Wit,J., Vermeulen,W., Bootsma,D.
and Hoeijmakers,J.H. (1992) ERCC6, a member of a subfamily of
putative helicases, is involved in Cockayne’s syndrome and
preferential repair of active genes. Cell, 71, 939–953.
5. Durr,H., Flaus,A., Owen-Hughes,T. and Hopfner,K.P. (2006) Snf2
family ATPases and DExx box helicases: diﬀerences and unifying
concepts from high-resolution crystal structures. Nucleic Acids Res.,
34, 4160–4167.
6. Citterio,E., Rademakers,S., van der Horst,G.T., van Gool,A.J.,
Hoeijmakers,J.H. and Vermeulen,W. (1998) Biochemical and
biological characterization of wild-type and ATPase-deﬁcient
1
10
100
1000
0 5 10 15 20
HmdU concentration (mM)
P
e
r
c
e
n
t
 
S
u
r
v
i
v
a
l
CSB-WT
CSB-V
1
10
100
1000
0 0.2 0.4 0.6 0.8 1 1.2 1.4
MMS concentration (mM)
P
e
r
c
e
n
t
 
S
u
r
v
i
v
a
l
CSB-WT
CSB-V
CSB-E646Q
A
B
Figure 5. CSB deﬁcient cells exhibit hypersensitivity to MMS and
HmdU. (A) MMS sensitivity. CSB-V, CSB-E646Q, and CSB-WT cells
were exposed to MMS at diﬀerent concentrations (indicated) for 1h,
and subsequently incubated for 10 days in drug-free medium. The
surviving fraction of cells (% survival) was calculated by dividing the
number of colonies in treated dishes by those counted in the untreated
control. (B) HmdU sensitivity. The indicated cell lines were exposed to
HmdU at diﬀerent concentrations (denoted) for 24h and plated in
complete media. The colony formation ability was determined after
10 days. Values shown in both panels represent the mean and standard
deviation of six independent data points.
Nucleic Acids Research, 2007, Vol. 35, No. 12 4111Cockayne syndrome B repair protein. J. Biol. Chem., 273,
11844–11851.
7. Selby,C.P. and Sancar,A. (1997) Human transcription-repair
coupling factor CSB/ERCC6 is a DNA-stimulated ATPase but is
not a helicase and does not disrupt the ternary transcription
complex of stalled RNA polymerase II. J. Biol. Chem., 272,
1885–1890.
8. Christiansen,M., Stevnsner,T., Modin,C., Martensen,P.M.,
Brosh,R.M.Jr and Bohr,V.A. (2003) Functional consequences of
mutations in the conserved SF2 motifs and post-translational
phosphorylation of the CSB protein. Nucleic Acids Res., 31,
963–973.
9. Citterio,E., van den Boom,V., Schnitzler,G., Kanaar,R., Bonte,E.,
Kingston,R.E., Hoeijmakers,J.H. and Vermeulen,W. (2000)
ATP-dependent chromatin remodeling by the Cockayne syndrome
B DNA repair-transcription-coupling factor. Mol. Cell. Biol., 20,
7643–7653.
10. Beerens,N., Hoeijmakers,J.H., Kanaar,R., Vermeulen,W. and
Wyman,C. (2005) The CSB protein actively wraps DNA.
J. Biol. Chem., 280, 4722–4729.
11. Muftuoglu,M., Sharma,S., Thorslund,T., Stevnsner,T.,
Soerensen,M.M., Brosh,R.M.Jr and Bohr,V.A. (2006) Cockayne
syndrome group B protein has novel strand annealing and exchange
activities. Nucleic Acids Res., 34, 295–304.
12. van Hoﬀen,A., Balajee,A.S., van Zeeland,A.A. and Mullenders,L.H.
(2003) Nucleotide excision repair and its interplay with transcrip-
tion. Toxicology, 193, 79–90.
13. Brosh,R.M. Jr, Balajee,A.S., Selzer,R.R., Sunesen,M., Proietti,D.S.
and Bohr,V.A. (1999) The ATPase domain but not the acidic region
of Cockayne syndrome group B gene product is essential for DNA
repair. Mol. Biol. Cell, 10, 3583–3594.
14. van Oosterwijk,M.F., Versteeg,A., Filon,R., van Zeeland,A.A. and
Mullenders,L.H. (1996) The sensitivity of Cockayne’s syndrome
cells to DNA-damaging agents is not due to defective transcription-
coupled repair of active genes. Mol. Cell. Biol., 16, 4436–4444.
15. Sunesen,M., Selzer,R.R., Brosh,R.M.Jr, Balajee,A.S., Stevnsner,T.
and Bohr,V.A. (2000) Molecular characterization of an acidic
region deletion mutant of Cockayne syndrome group B protein.
Nucleic Acids Res., 28, 3151–3159.
16. Mayne,L.V. and Lehmann,A.R. (1982) Failure of RNA synthesis to
recover after UV irradiation: an early defect in cells from
individuals with Cockayne’s syndrome and xeroderma
pigmentosum. Cancer Res., 42, 1473–1478.
17. Laine,J.P. and Egly,J.M. (2006) When transcription and repair
meet: a complex system. Trends Genet., 22, 430–436.
18. Tantin,D., Kansal,A. and Carey,M. (1997) Recruitment of the
putative transcription-repair coupling factor CSB/ERCC6 to RNA
polymerase II elongation complexes. Mol. Cell. Biol., 17,
6803–6814.
19. van den Boom,V., Citterio,E., Hoogstraten,D., Zotter,A.,
Egly,J.M., van Cappellen,W.A., Hoeijmakers,J.H.,
Houtsmuller,A.B. and Vermeulen,W. (2004) DNA damage stabilizes
interaction of CSB with the transcription elongation machinery.
J. Cell. Biol., 166, 27–36.
20. Laine,J.P. and Egly,J.M. (2006) Initiation of DNA repair mediated
by a stalled RNA polymerase IIO. EMBO J., 25, 387–397.
21. Fousteri,M., van,H.A., Vargova,H. and Mullenders,L.H. (2005)
Repair of DNA lesions in chromosomal DNA impact of chromatin
structure and Cockayne syndrome proteins. DNA Repair, 4,
919–925.
22. Bradsher,J., Auriol,J., Proietti De,S.L., Iben,S., Vonesch,J.L.,
Grummt,I. and Egly,J.M. (2002) CSB is a component of RNA pol I
transcription. Mol. Cell, 10, 819–829.
23. Balajee,A.S., May,A., Dianov,G.L., Friedberg,E.C. and Bohr,V.A.
(1997) Reduced RNA polymerase II transcription in intact and
permeabilized Cockayne syndrome group B cells. Proc. Natl Acad.
Sci. USA, 94, 4306–4311.
24. Tantin,D. (1998) RNA polymerase II elongation complexes
containing the Cockayne syndrome group B protein interact with
a molecular complex containing the transcription factor IIH
components xeroderma pigmentosum B and p62. J. Biol. Chem.,
273, 27794–27799.
25. van Gool,A.J., Citterio,E., Rademakers,S., van Os,R.,
Vermeulen,W., Constantinou,A., Egly,J.M., Bootsma,D. and
Hoeijmakers,J.H. (1997) The Cockayne syndrome B protein,
involved in transcription-coupled DNA repair, resides in
an RNA polymerase II-containing complex. EMBO J., 16,
5955–5965.
26. Tuo,J., Muftuoglu,M., Chen,C., Jaruga,P., Selzer,R.R.,
Brosh,R.M.Jr, Rodriguez,H., Dizdaroglu,M. and Bohr,V.A. (2001)
The Cockayne Syndrome group B gene product is involved in
general genome base excision repair of 8-hydroxyguanine in DNA.
J. Biol. Chem., 276, 45772–45779.
27. de Waard,H., de Wit,J., Gorgels,T.G., van den,A.G.,
Andressoo,J.O., Vermeij,M., van Steeg,H., Hoeijmakers,J.H. and
van der Horst,G.T. (2003) Cell type-speciﬁc hypersensitivity to
oxidative damage in CSB and XPA mice. DNA Repair, 2, 13–25.
28. de Waard,H., de Wit,J., Andressoo,J.O., van Oostrom,C.T., Riis,B.,
Weimann,A., Poulsen,H.E., van Steeg,H., Hoeijmakers,J.H. et al.
(2004) Diﬀerent eﬀects of CSA and CSB deﬁciency on sensitivity to
oxidative DNA damage. Mol. Cell. Biol., 24, 7941–7948.
29. Osterod,M., Larsen,E., Le Page,F., Hengstler,J.G., van der
Horst,G.T., Boiteux,S., Klungland,A. and Epe,B. (2002) A global
DNA repair mechanism involving the Cockayne syndrome B (CSB)
gene product can prevent the in vivo accumulation of endogenous
oxidative DNA base damage. Oncogene, 21, 8232–8239.
30. Sunesen,M., Stevnsner,T., Brosh,R.M. Jr, Dianov,G.L. and
Bohr,V.A. (2002) Global genome repair of 8-oxoG in hamster cells
requires a functional CSB gene product. Oncogene, 21, 3571–3578.
31. Stevnsner,T., Nyaga,S., Souza-Pinto,N.C., van der Horst,G.T.,
Gorgels,T.G., Hogue,B.A., Thorslund,T. and Bohr,V.A. (2002)
Mitochondrial repair of 8-oxoguanine is deﬁcient in Cockayne
syndrome group B. Oncogene, 21, 8675–8682.
32. Trapp,C., Reite,K., Klungland,A. and Epe,B. Deﬁciency of the
Cockayne syndrome B (CSB) gene aggravates the genomic
instability caused by endogenous oxidative DNA base damage in
mice. Oncogene, Epub ahead of print.
33. Tuo,J., Jaruga,P., Rodriguez,H., Bohr,V.A. and Dizdaroglu,M.
(2003) Primary ﬁbroblasts of Cockayne syndrome patients are
defective in cellular repair of 8-hydroxyguanine and 8-hydroxyade-
nine resulting from oxidative stress. FASEB J., 17, 668–674.
34. Flohr,C., Burkle,A., Radicella,J.P. and Epe,B. (2003)
Poly(ADP-ribosyl)ation accelerates DNA repair in a pathway
dependent on Cockayne syndrome B protein. Nucleic Acids Res., 31,
5332–5337.
35. Thorslund,T., von Kobbe,C., Harrigan,J.A., Indig,F.E.,
Christiansen,M., Stevnsner,T. and Bohr,V.A. (2005) Cooperation of
the Cockayne syndrome group B protein and poly(ADP-ribose)
polymerase 1 in the response to oxidative stress. Mol. Cell. Biol., 25,
7625–7636.
36. Spivak,G. and Hanawalt,P.C. (2006) Host cell reactivation of
plasmids containing oxidative DNA lesions is defective in Cockayne
syndrome but normal in UV-sensitive syndrome ﬁbroblasts. DNA
Repair, 5, 13–22.
37. Check,E. (2005) Retracted papers damage work on DNA repair.
Nature, 435, 1015.
38. Andressoo,J.O. and Hoeijmakers,J.H. (2005) Transcription-coupled
repair and premature ageing. Mutat. Res., 577, 179–194.
39. Wilson,D.M.III and Barsky,D. (2001) The major human abasic
endonuclease: formation, consequences and repair of abasic lesions
in DNA. Mutat. Res., 485, 283–307.
40. Hu,J., Imam,S.Z., Hashiguchi,K., de Souza-Pinto,N.C. and
Bohr,V.A. (2005) Phosphorylation of human oxoguanine DNA
glycosylase (alpha-OGG1) modulates its function. Nucleic Acids
Res., 33, 3271–3282.
41. Muftuoglu,M., Wong,H.K., Imam,S.Z., Wilson,D.M.III, Bohr,V.A.
and Opresko,P.L. (2006) Telomere Repeat Binding Factor 2
Interacts with Base Excision Repair Proteins and Stimulates DNA
Synthesis by DNA Polymerase {beta}. Cancer Res., 66, 113–124.
42. Erzberger,J.P., Barsky,D., Scharer,O.D., Colvin,M.E. and
Wilson,D.M.III. (1998) Elements in abasic site recognition by
the major human and Escherichia coli apurinic/apyrimidinic
endonucleases. Nucleic Acids Res., 26, 2771–2778.
43. Cheng,W.H., von,K.C., Opresko,P.L., Fields,K.M., Ren,J., Kufe,D.
and Bohr,V.A. (2003) Werner syndrome protein phosphorylation by
abl tyrosine kinase regulates its activity and distribution. Mol. Cell.
Biol., 23, 6385–6395.
4112 Nucleic Acids Research, 2007, Vol. 35, No. 1244. Wilson,D.M.III. (2005) Ape1 abasic endonuclease activity is
regulated by magnesium and potassium concentrations and is
robust on alternative DNA structures. J. Mol. Biol., 345,
1003–1014.
45. McNeill,D.R., Narayana,A., Wong,H.K. and Wilson,D.M.III.
(2004) Inhibition of Ape1 nuclease activity by lead, iron, and
cadmium. Environ. Health Perspect., 112, 799–804.
46. Wong,H.K., Kim,D., Hogue,B.A., McNeill,D.R. and
Wilson,D.M.III. (2005) DNA damage levels and biochemical repair
capacities associated with XRCC1 deﬁciency. Biochemistry, 44,
14335–14343.
47. Mayne,L.V., Priestley,A., James,M.R. and Burke,J.F. (1986)
Eﬃcient immortalization and morphological transformation of
human ﬁbroblasts by transfection with SV40 DNA linked to a
dominant marker. Exp. Cell Res., 162, 530–538.
48. Selzer,R.R., Nyaga,S., Tuo,J., May,A., Muftuoglu,M.,
Christiansen,M., Citterio,E., Brosh,R.M. Jr and Bohr,V.A. (2002)
Diﬀerential requirement for the ATPase domain of the Cockayne
syndrome group B gene in the processing of UV-induced DNA
damage and 8-oxoguanine lesions in human cells. Nucleic Acids
Res., 30, 782–793.
49. Wong,H.K. and Wilson,D.M.III. (2005) XRCC1 and DNA
polymerase beta interaction contributes to cellular alkylating-agent
resistance and single-strand break repair. J. Cell. Biochem., 95,
794–804.
50. Wilson,D.M.III, Takeshita,M., Grollman,A.P. and Demple,B.
(1995) Incision activity of human apurinic endonuclease (Ape) at
abasic site analogs in DNA. J. Biol. Chem., 270, 16002–16007.
51. Mol,C.D., Hosﬁeld,D.J. and Tainer,J.A. (2000) Abasic site recog-
nition by two apurinic/apyrimidinic endonuclease families in DNA
base excision repair: the 30 ends justify the means. Mutat. Res., 460,
211–229.
52. Mol,C.D., Izumi,T., Mitra,S. and Tainer,J.A. (2000) DNA-bound
structures and mutants reveal abasic DNA binding by APE1 and
DNA repair coordination. Nature, 403, 451–456.
53. Wilson,D.M.III, Takeshita,M. and Demple,B. (1997) Abasic site
binding by the human apurinic endonuclease, Ape, and determina-
tion of the DNA contact sites. Nucleic Acids Res., 25, 933–939.
54. Nakamura,J., Walker,V.E., Upton,P.B., Chiang,S.Y., Kow,Y.W.
and Swenberg,J.A. (1998) Highly sensitive apurinic/apyrimidinic site
assay can detect spontaneous and chemically induced depurination
under physiological conditions. Cancer Res., 58, 222–225.
55. Wyatt,M.D. and Pittman,D.L. (2006) Methylating agents and DNA
repair responses: Methylated bases and sources of strand breaks.
Chem. Res. Toxicol., 19, 1580–1594.
56. Boorstein,R.J., Cummings,A.Jr, Marenstein,D.R., Chan,M.K.,
Ma,Y., Neubert,T.A., Brown,S.M. and Teebor,G.W. (2001)
Deﬁnitive identiﬁcation of mammalian 5-hydroxymethyluracil DNA
N-glycosylase activity as SMUG1. J. Biol. Chem., 276,
41991–41997.
57. Boorstein,R.J., Chiu,L.N. and Teebor,G.W. (1992) A mammalian
cell line deﬁcient in activity of the DNA repair enzyme
5-hydroxymethyluracil-DNA glycosylase is resistant to the toxic
eﬀects of the thymidine analog 5-hydroxymethyl-2’-deoxyuridine.
Mol. Cell. Biol., 12, 5536–5540.
58. Fousteri,M., Vermeulen,W., van Zeeland,A.A. and Mullenders,L.H.
(2006) Cockayne syndrome A and B proteins diﬀerentially regulate
recruitment of chromatin remodeling and repair factors to stalled
RNA polymerase II in vivo. Mol. Cell, 23, 471–482.
59. Christiansen,M., Thorslund,T., Jochimsen,B., Bohr,V.A. and
Stevnsner,T. (2005) The Cockayne syndrome group B protein is a
functional dimer. FEBS J., 272, 4306–4314.
60. Demple,B. and DeMott,M.S. (2002) Dynamics and diversions in
base excision DNA repair of oxidized abasic lesions. Oncogene, 21,
8926–8934.
61. Gros,L., Ishchenko,A.A., Ide,H., Elder,R.H. and Saparbaev,M.K.
(2004) The major human AP endonuclease (Ape1) is involved in the
nucleotide incision repair pathway. Nucleic Acids Res., 32, 73–81.
62. Verly,W.G., Tuy,M., Brakier,L. and James,M. (1970) Interaction
between T7 coliphage denatured DNA and Sarcina lutea RNA.
Biochim. Biophys. Acta, 217, 192–195.
63. Boule-Charest,L. and Mamet-Bratley,M.D. (1972) Initiation by
RNA polymerase on alkylated T7 DNA. Biochim. Biophys. Acta,
277, 276–279.
64. Flamee,P.A. and Verly,W.G. (1985) Action of intact AP
(apurinic/apyrimidinic) sites and AP sites associated with breaks on
the transcription of T7 coliphage DNA by Escherichia coli RNA
polymerase. Biochem. J., 229, 173–181.
65. Zhou,W. and Doetsch,P.W. (1993) Eﬀects of abasic sites and DNA
single-strand breaks on prokaryotic RNA polymerases. Proc. Natl
Acad. Sci. USA, 90, 6601–6605.
66. Sanchez,G., Racine,J.F. and Mamet-Bratley,M.D. (1994) Eﬀect of
abasic sites on bacteriophage T7 protein synthesis. Mutat. Res., 325,
39–45.
67. Sanchez,G. and Mamet-Bratley,M.D. (1994) Transcription by T7
RNA polymerase of DNA containing abasic sites. Environ.
Mol. Mutagen., 23, 32–36.
68. Wang,Y., Sheppard,T.L., Tornaletti,S., Maeda,L.S. and
Hanawalt,P.C. (2006) Transcriptional inhibition by an oxidized
abasic site in DNA. Chem. Res. Toxicol., 19, 234–241.
69. Sarker,A.H., Tsutakawa,S.E., Kostek,S., Ng,C., Shin,D.S.,
Peris,M., Campeau,E., Tainer,J.A., Nogales,E. et al. (2005)
Recognition of RNA polymerase II and transcription bubbles by
XPG, CSB, and TFIIH: insights for transcription-coupled repair
and Cockayne Syndrome. Mol. Cell, 20, 187–198.
70. Kathe,S.D., Shen,G.P. and Wallace,S.S. (2004) Single-stranded
breaks in DNA but not oxidative DNA base damages block
transcriptional elongation by RNA polymerase II in HeLa cell
nuclear extracts. J. Biol. Chem., 279, 18511–18520.
71. Plosky,B., Samson,L., Engelward,B.P., Gold,B., Schlaen,B.,
Millas,T., Magnotti,M., Schor,J. and Scicchitano,D.A. (2002) Base
excision repair and nucleotide excision repair contribute to the
removal of N-methylpurines from active genes. DNA Repair, 1,
683–696.
72. Luo,M. and Kelley,M.R. (2004) Inhibition of the human apurinic/
apyrimidinic endonuclease (APE1) repair activity and sensitization
of breast cancer cells to DNA alkylating agents with lucanthone.
Anticancer Res., 24, 2127–2134.
73. Sobol,R.W., Horton,J.K., Kuhn,R., Gu,H., Singhal,R.K.,
Prasad,R., Rajewsky,K. and Wilson,S.H. (1996) Requirement of
mammalian DNA polymerase-beta in base-excision repair. Nature,
379, 183–186.
74. Thompson,L.H., Brookman,K.W., Jones,N.J., Allen,S.A. and
Carrano,A.V. (1990) Molecular cloning of the human XRCC1
gene, which corrects defective DNA strand break repair and
sister chromatid exchange. Mol. Cell. Biol., 10, 6160–6171.
75. Ding,R. and Smulson,M. (1994) Depletion of nuclear
poly(ADP-ribose) polymerase by antisense RNA expression: inﬂu-
ences on genomic stability, chromatin organization, and carcinogen
cytotoxicity. Cancer Res., 54, 4627–4634.
76. Trucco,C., Oliver,F.J., de,M.G. and Menissier-de,M.J. (1998) DNA
repair defect in poly(ADP-ribose) polymerase-deﬁcient cell lines.
Nucleic Acids Res., 26, 2644–2649.
77. Madhusudan,S., Smart,F., Shrimpton,P., Parsons,J.L., Gardiner,L.,
Houlbrook,S., Talbot,D.C., Hammonds,T., Freemont,P.A. et al.
(2005) Isolation of a small molecule inhibitor of DNA base excision
repair. Nucleic Acids Res., 33, 4711–4724.
78. Horton,J.K., Joyce-Gray,D.F., Pachkowski,B.F., Swenberg,J.A.
and Wilson,S.H. (2003) Hypersensitivity of DNA polymerase beta
null mouse ﬁbroblasts reﬂects accumulation of cytotoxic repair
intermediates from site-speciﬁc alkyl DNA lesions. DNA Repair, 2,
27–48.
79. Horton,J.K., Stefanick,D.F., Naron,J.M., Kedar,P.S. and
Wilson,S.H. (2005) Poly(ADP-ribose) polymerase activity prevents
signaling pathways for cell cycle arrest after DNA methylating
agent exposure. J. Biol. Chem., 280, 15773–15785.
80. Fan,J. and Wilson,D.M.III. (2005) Protein-protein interactions
and posttranslational modiﬁcations in mammalian base excision
repair. Free Radic. Biol. Med., 38, 1121–1138.
81. Muftuoglu,M., Selzer,R., Tuo,J., Brosh,R.M.Jr and Bohr,V.A.
(2002) Phenotypic consequences of mutations in the conserved
motifs of the putative helicase domain of the human Cockayne
syndrome group B gene. Gene, 283, 27–40.
Nucleic Acids Research, 2007, Vol. 35, No. 12 4113